98%
921
2 minutes
20
Objective: To develop and pilot test a combined-learning intervention for Tanzanian primary healthcare workers on ear and hearing care (EHC), comprising five self-led smartphone-based modules and in-person workshops.
Design: The intervention was piloted with primary healthcare workers in Tanzania. Pre- and post-training surveys assessed knowledge, confidence, and attitudes towards EHC via Likert scales. Statistical analysis (paired -tests, McNemar tests) evaluated outcomes; < 0.05 was considered statistically significant.
Study Sample: 24 local Tanzanian primary healthcare workers.
Results: Post-training, participants showed significant improvements in EHC education and skills, including auditory pathology and anatomy ( < 0.01), cerumen extraction ( < 0.01), infection prevention protocols ( < 0.01), otoscopy ( = 0.02), paediatric referral protocols ( = 0.02), diagnostic identification of common otologic conditions ( < 0.01), and management of ear discharge ( < 0.01). However, confidence in interpreting audiograms ( = 0.08) and tympanograms ( = 0.19) remained unchanged, with participants requesting further hands-on training.
Conclusions: Smartphone-based learning paired with in-person training effectively enhanced practical EHC skills among primary healthcare workers, supporting task-shifting in low-resource settings. Perceived gaps in interpreting audiological tests highlight the need for further hands-on training. This model demonstrates scalability potential, particularly with rising smartphone access in Africa. Future iterations should prioritise longitudinal competency assessments and adaptive content to address clinical interpretation challenges, advancing equitable EHC delivery.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1080/14992027.2025.2549462 | DOI Listing |
Hum Genet
September 2025
College of Otolaryngology Head and Neck Surgery, Chinese PLA General Hospital, Chinese PLA Medical School, 28 Fuxing Road, Beijing, 100853, China.
Recessive variants in TWNK cause syndromes arising from mitochondrial DNA (mtDNA) depletion. Hearing loss is the most prevalent manifestation in individuals with these disorders. However, the clinical and pathophysiological features have not been fully elucidated.
View Article and Find Full Text PDFInquiry
September 2025
MED-EL-GmbH, Innsbruck, Austria.
Introduction: Age related hearing loss is in the top ten contributors to the global burden of disease and one of the largest modifiable risk factors for age-related dementia. However, awareness of the consequences of untreated hearing loss is poor and many adults do not seek hearing assessment. Despite World Health Organisation recommendations, no EU country currently has a national adult screening programme.
View Article and Find Full Text PDFOtolaryngol Head Neck Surg
September 2025
Departament de Cirurgia i Especialitats Medicoquirúrgiques, Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, Barcelona, Spain.
Objective: To conduct a systematic review and meta-analysis to assess the association between type 2 diabetes and hearing loss.
Data Sources: Search conducted in PubMed and Scopus databases for articles published between January 2019 and April 2024.
Review Methods: Quality assessment and risk of bias analysis were conducted using the Newcastle-Ottawa scale, and meta-analyses of pooled data were performed with Cochrane's Review Manager.
Ear Nose Throat J
September 2025
Department of Primary Care, Ohio University Heritage College of Osteopathic Medicine, The Ohio University Diabetes Institute, Athens, OH, USA.
Background: Hearing loss is a significant public health issue in the United States, affecting an estimated 72.9 million people, or 22% of the population. Despite its prevalence and clinical impact, insurance coverage for hearing-related interventions remains inconsistent.
View Article and Find Full Text PDFJ Assoc Res Otolaryngol
September 2025
Biological Sciences Platform, Hurvitz Brain Sciences Program, Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, 2075 Bayview Ave., Room M1 102, Toronto, ON, M4N 3M5, Canada.
Purpose: Delivery of therapeutics to the inner ear is complicated by their inaccessible location and the presence of the blood-labyrinth barrier that restricts most blood-borne compounds from entering the inner ear. This study addresses the challenge of optimal delivery in treating inner ear disease, focusing on magnetic targeting gene therapy using adeno-associated virus (AAV).
Methods: The investigation explores three AAV serotypes (AAV2 Quad Mut, AAV2 pANC80L65, and AAV9 PHP.